Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Goodwill & Intangibles (2023 - 2025)

Connect Biopharma Holdings' Goodwill & Intangibles history spans 3 years, with the latest figure at $47000.0 for Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed N/A year-over-year to $47000.0; the TTM value through Sep 2025 reached $47000.0, changed N/A, while the annual FY2024 figure was $53000.0, 14.52% down from the prior year.
  • Goodwill & Intangibles for Q3 2025 was $47000.0 at Connect Biopharma Holdings, down from $48000.0 in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $62000.0 in Q4 2023 and bottomed at $47000.0 in Q3 2025.
  • The 3-year median for Goodwill & Intangibles is $50000.0 (2025), against an average of $52000.0.
  • The largest YoY upside for Goodwill & Intangibles was 14.52% in 2024 against a maximum downside of 14.52% in 2024.
  • A 3-year view of Goodwill & Intangibles shows it stood at $62000.0 in 2023, then decreased by 14.52% to $53000.0 in 2024, then fell by 11.32% to $47000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTB's Goodwill & Intangibles are $47000.0 (Q3 2025), $48000.0 (Q2 2025), and $50000.0 (Q1 2025).